News & Topics

HOME > News & Topics
[International Symposium]The 1st UCL-OU Joint Symposium on Immunology(Jun.27-28/2019)
Prof. Takeda,inaugurated to be the new director of IFReC
Science Cafe at KNOWLEDE CAPITAL vol.3 in 2019
Shimon Sakaguchi wins Kazuhiko Yamada Prize
CXCR4 regulates Plasmodium development in mouse and human hepatocytes (Yamamoto G in JEM)
Article by IFReC Researchers Rank Highly in the "Most Cited Articles of the Heisei Period"
The 9th Winter School on Advanced Immunology
【Visitor】Senior High School at Komaba, Univ. of Tsukuba
Science Cafe at KNOWLEDE CAPITAL vol.2 in 2019
IL-17-mediated phosphorylation of Regnase-1 (Akira G in JEM)
The COMMD3/8 complex determines GRK6 specificity for chemoattractant receptors (Suzuki group in JEM)
Icho FESTIVAL・Science Cafe on the edge[May 2]
Science Cafe at KNOWLEDE CAPITAL vol.1 in 2019
Introductory Lectures to Conduct Research in Japan [Apr.24]
Knowledge Capital Workshop Fes, 2019 SPRING
Takashi NAGASAWA to receive the Japan Academy Prize.
Regnase-1-mediated post-transcriptional regulation is essential for hematopoietic stem and progenitor cell homeostasis (Takakura group in Nat Commun)
IFReC participated in AAAS 2019 annual meeting
RIMD/IFReC Joint Orientation and Lab tour 2019[May 25]
[Seminar] Motohiko Kadoki (Feb.22)
Impact of sarcopenia in patients with advanced non-small cell lung cancer treated with PD-1 inhibitors (Kumanogoh group in Sci Rep)
[International Symposium]Next Gen Immunology in Health and Disease(Feb.7-8/2019)
Satb1 regulates the effector program of encephalitogenic tissue Th17 cells in chronic inflammation (Sakaguchi group in Nat Commun)
Osaka University and the three companies awareded by Minister of Education, Culture, Sports, Science and Technology.
Genetic and phenotypic landscape of the MHC region in the Japanese population(Okada group in Nat Gen)
The 8th Winter School on Advanced Immunology
TAK1 Prevents Endothelial Apoptosis and Maintains Vascular Integrity (Takakura group, in Dev. Cell)
Semaphorin 7A promotes EGFR-TKI resistance in EGFR mutant lung adenocarcinoma cells (Kumanogoh group, in NAR)